Identification of Novel Bioactive Compound Derived from Rheum officinalis against Campylobacter jejuni NCTC11168
Gastric diseases are increasing with the infection of Campylobacter jejuni. Late stages of infection lead to peptic ulcer and gastric carcinoma. C. jejuni infects people within different stages of their life, especially childhood, causing severe diarrhea; it infects around two-thirds of the world po...
Main Authors: | Mohammed Yosri, Basma H. Amin, Nermine N. Abed, Amal S. Elithy, Sayed M. Kareem, Nagwa M. Sidkey |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2020-01-01
|
Series: | The Scientific World Journal |
Online Access: | http://dx.doi.org/10.1155/2020/3591276 |
Similar Items
-
Transcriptomic analysis of Campylobacter jejuni NCTC 11168 in response to epinephrine and norepinephrine
by: Fuzhou eXu, et al.
Published: (2015-05-01) -
Re-annotation and re-analysis of the <it>Campylobacter jejuni </it>NCTC11168 genome sequence
by: Dorrell Nick, et al.
Published: (2007-06-01) -
Comparative variation within the genome of Campylobacter jejuni NCTC 11168 in human and murine hosts.
by: Dallas K Thomas, et al.
Published: (2014-01-01) -
Re-annotation of the Campylobacter jejuni NCTC11168 genome and functional characterisation of selected genes involved in strain pathogenesis
by: Gundogdu, Ozan
Published: (2011) -
High Throughput Method for Analysis of Repeat Number for 28 Phase Variable Loci of Campylobacter jejuni Strain NCTC11168.
by: Lea Lango-Scholey, et al.
Published: (2016-01-01)